The Foundation is delighted to welcome onboard two new support partners, Catchi and Waking Giants. Cornelis and Grant, from Catchi and Waking Giants respectively, are highly respected experts in their fields and are a very welcome addition joining Sam Ramlu from Method Studio insuring the Foundations communication and IT optimisation is cutting edge.
When talking to companies about Conversion Rate Optimisation we notice that for many of them this is still pretty new territory. At the same time it’s such a big eye opener once they start to get an understanding of what it’s all about; most companies get very excited about its potential impact on their business and revenue.
At the heart of communication is education – when you are educated you can make better decisions for your brand.
+ strategy + ideation + brand development + communication + graphic design + identity + logo design + interface + website design + social media marketing + online marketing
The Epilepsy Foundation is delighted with the financial support received from Pharmaceutical giant bioCSL. “We at bioCSL wish to raise the awareness and understanding of epilepsy in New Zealand” said Claire Jackson from bioCSL.
bioCSL New Zealand markets vaccines and pharmaceutical products in New Zealand with a focus on products for the prevention and treatment of serious disease. We also in-license a number of products from partner companies to ensure a comprehensive range of products available to New Zealanders. CSL Pharmaceuticals was set up in New Zealand in 1991 and changed its name to CSL Biotherapies in 2006 in line with changes across the CSL Group.
What is Vimpat®?
Vimpat® (lacosamide) is a prescription medicine that is used with other medicines (added on) to treat partial onset seizures in people 16 years of age and older with epilepsy.
Ask your doctor if you have any questions about why Vimpat® has been prescribed for you. Vimpat® is FULLY FUNDED under Special Authority and funding criteria applies. If you meet the funding criteria all you’ll pay are normal doctor’s fees and pharmacy charges.